Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benign Paroxysmal Positional Vertigo Recurrence After Canalith Re-positioning: A 12-Month Prospective Cohort Comparison of Vitamin D₃ Plus K₂, Vitamin D₃ Alone, and Maneuver Alone.

NCT07861464 is registered in ClinicalTrials.gov with University of Jordan as lead sponsor.

NCT NCT07861464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benign Paroxysmal Positional Vertigo Recurrence After Canalith Re-positioning: A 12-Month Prospective Cohort Comparison of Vitamin D₃ Plus K₂, Vitamin D₃ Alone, and Maneuver Alone.
Lead sponsor
University of Jordan
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2025
Completion date
August 31, 2026
Enrollment
404 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign paroxismal positional vertigo